GSEP
CL icon

Golden State Equity Partners’s Colgate-Palmolive CL Stock Holding History

Golden State Equity Partners’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$193K Sell
2,262
-1,318
-37% -$117K 0.01% 637
2025
Q4 		$283K Buy
3,580
+317
+10% +$24.9K 0.05% 408
2025
Q3 		$261K Buy
3,263
+436
+15% +$37.2K 0.04% 377
2025
Q2 		$257K Sell
2,827
-9,340
-77% -$853K 0.05% 366
2025
Q1 		$1.14M Buy
12,167
+4,676
+62% +$419K 0.23% 115
2024
Q4 		$681K Buy
7,491
+2,696
+56% +$257K 0.13% 183
2024
Q3 		$499K Buy
4,795
+2,162
+82% +$220K 0.26% 89
2024
Q2 		$255K Buy
+2,633
New +$243K 0.05% 344
2023
Q4 		$200K Sell
2,514
-361
-13% -$27.1K 0.05% 344
2023
Q3 		$204K Buy
2,875
+11
+0.4% +$822 0.06% 310
2023
Q2 		$221K Sell
2,864
-64
-2% -$4.95K 0.06% 330
2023
Q1 		$220K Buy
+2,928
New +$218K 0.12% 189

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Golden State Equity Partners's CL Position: Q1 2026 in Review

Golden State Equity Partners reduced its Colgate-Palmolive (CL) stake by 37% in Q1 2026, selling an estimated $117K and leaving 2,262 shares worth $193K. The position accounts for 0.01% of the portfolio, ranked #637.

Golden State Equity Partners first reported a position in CL in Q1 2023 and has held it in 12 quarters since. The position peaked at $1.14M in Q1 2025. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Golden State Equity Partners held 2,262 shares of Colgate-Palmolive worth $193K as of Q1 2026.
  • Golden State Equity Partners sold 1,318 Colgate-Palmolive shares in Q1 2026, an estimated $117K.
  • Colgate-Palmolive made up 0.01% of Golden State Equity Partners's portfolio in Q1 2026, its #637 holding.
  • Golden State Equity Partners first reported a position in Colgate-Palmolive in Q1 2023 and has held it in 12 quarters since.
  • Golden State Equity Partners's Colgate-Palmolive position peaked at $1.14M in Q1 2025.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Golden State Equity Partners's 13F filing for Q1 2026, filed 28 Apr 2026.